The constitutive activation of Egr-1/C/Ebpa mediates the development of type 2 diabetes mellitus by enhancing hepatic gluconeogenesis

American Journal of Pathology

Volumn 185, Issue 2, 2015, Pages 513-523

  Shen, Ning ^a   Jiang, Shan ^a   Lu, Jia Ming ^a   Yu, Xiao ^a   Lai, Shan Shan ^a   Zhang, Jing Zi ^a   Zhang, Jin Long ^a   Tao, Wei Wei ^a   Wang, Xiu Xing ^a   Xu, Na ^a   Xue, Bin ^a   Li, Chao Jun ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; GLUCAGON; GLYCOGEN; INSULIN; PYRUVIC ACID; TRANSCRIPTION FACTOR EGR 1; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, MOUSE; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, MOUSE; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; INSULIN RELEASE; LIVER CELL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROMOTER REGION; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; EARLY GROWTH RESPONSE PROTEIN 1; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; LIVER; MALE; MICE;

EID: 84922337132     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.10.016     Document Type: Article

References (38)

1. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806
2. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935
3. Kahn S: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003, 46:3-19
4. Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846
5. Unger RH, Cherrington AD: Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest 2012, 122:4-12
6. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR: Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000, 49:2063-2069
7. Natali A, Ferrannini E: Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia 2006, 49: 434-441
8. Ali S, Drucker DJ: Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes. Am J Physiol Endocrinol Metab 2009, 296:E415-E421
9. Dinneen S, Alzaid A, Turk D, Rizza R: Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 1995, 38:337-343
10. Shah P, Basu A, Basu R, Rizza R: Impact of lack of suppression of glucagon on glucose tolerance in humans. Am J Physiol Endocrinol Metab 1999, 277:E283-E290
11. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA: Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 2000, 85:4053-4059
12. Hancock AS, Du A, Liu J, Miller M, May CL: Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice. Mol Endocrinol 2010, 24:1605-1614
13. Wang M-Y, Chen L, Clark GO, Lee Y, Stevens RD, Ilkayeva OR, Wenner BR, Bain JR, Charron MJ, Newgard CB: Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci U S A 2010, 107: 4813-4819
14. Edgerton DS, Cherrington AD: Glucagon as a critical factor in the pathology of diabetes. Diabetes 2011, 60:377-380
15. Shen N, Yu X, Pan F-Y, Gao X, Xue B, Li C-J: An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism. J Biol Chem 2011, 286: 14508-14515
16. Zhang J, Zhang Y, Sun T, Guo F, Huang S, Chandalia M, Abate N, Fan D, Xin H-B, Chen YE: Dietary obesity-induced Egr-1 in adipocytes facilitates energy storage via suppression of FOXC2. Sci Rep 2013, 3:1476
17. Berasi SP, Huard C, Li D, Shih HH, Sun Y, Zhong W, Paulsen JE, Brown EL, Gimeno RE, Martinez RV: Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMPactivated kinase. J Biol Chem 2006, 281:27167-27177
18. Hamilton TB, Borel F, Romaniuk PJ: Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1. Biochemistry 1998, 37:2051-2058
19. Silverman ES, Collins T: Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol 1999, 154:665-670
20. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, de Belle I: The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol 2001, 3: 1124-1128
21. Yao J, Mackman N, Edgington TS, Fan ST: Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells: regulation by Egr-1, c-Jun, and NF-kappa B transcription factors. J Biol Chem 1997, 272:17795
22. Shen N, Shao Y, Lai S-S, Qiao L, Yang R-L, Xue B, Pan F-Y, Chen H-Q, Li C-J: GGPPS, a new EGR-1 target gene, reactivates ERK 1/2 signaling through increasing Ras prenylation. Am J Pathol 2011, 179:2740-2750
23. Chavrier P, Zerial M, Lemaire P, Almendral J, Bravo R, Charnay P: A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells. EMBO J 1988, 7:29
24. Huang R-P, Liu C, Fan Y, Mercola D, Adamson ED: Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res 1995, 55:5054-5062
25. Hodge C, Liao J, Stofega M, Guan K, Carter-Su C, Schwartz J: Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem 1998, 273:31327-31336
26. Kang J-H, Kim M-J, Jang H-I, Koh K-H, Yum K-S, Rhie D-J, Yoon SH, Hahn SJ, Kim M-S, Jo Y-H: Proximal cyclic AMP response element is essential for exendin-4 induction of rat EGR-1 gene. Am J Physiol Endocrinol Metab 2007, 292:E215-E222
27. Keeton AB, Bortoff KD, Bennett WL, Franklin JL, Venable DY, Messina JL: Insulin-regulated expression of Egr-1 and Krox20: dependence on ERK1/2 and interaction with p38 and PI3-kinase pathways. Endocrinology 2003, 144:5402-5410
28. Yu X, Shen N, Zhang M-L, Pan F-Y, Wang C, Jia W-P, Liu C, Gao Q, Gao X, Xue B: Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice. EMBO J 2011, 30: 3754-3765
29. Wolfrum C, Shi S, Jayaprakash KN, Jayaraman M, Wang G, Pandey RK, Rajeev KG, Nakayama T, Charrise K, Ndungo EM: Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol 2007, 25:1149-1157
30. Morita M, Watanabe Y, Akaike T: Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 1995, 21:1585-1593
31. Emilsson V, Liu Y-L, Cawthorne MA, Morton NM, Davenport M: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997, 46:313-316
32. Fineman M, Weyer C, Maggs D, Strobel S, Kolterman O: The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res 2002, 34: 504-508
33. Koo S-H, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P: The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111
34. Josefsen K, Sørensen L, Buschard K, Birkenbach M: Glucose induces early growth response gene (Egr-1) expression in pancreatic beta cells. Diabetologia 1999, 42:195-203
35. Garnett KE, Chapman P, Chambers JA, Waddell ID, Boam DS: Differential gene expression between Zucker Fatty rats and Zucker Diabetic Fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation. J Mol Endocrinol 2005, 35:13-25
36. Gousseva N, Kugathasan K, Chesterman CN, Khachigian LM: Early growth response factor-1 mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injury. J Cell Biochem 2001, 81:523-534
37. Yechoor VK, Patti M-E, Saccone R, Kahn CR: Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc Natl Acad Sci U S A 2002, 99: 10587-10592
38. Handschin C, Spiegelman BM: The role of exercise and PGC1α in inflammation and chronic disease. Nature 2008, 454:463-469